financetom
Business
financetom
/
Business
/
OpenAI to remain under non-profit control in change of restructuring plans
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
OpenAI to remain under non-profit control in change of restructuring plans
May 26, 2025 1:25 AM

(Reuters) -OpenAI will remain under the control of a non-profit, the startup at the heart of the generative artificial intelligence boom said on Monday, months after it outlined plans to revamp its structure to create a public benefit corporation that would make it easier to raise capital.

OpenAI's non-profit will continue to oversee the company, CEO Sam Altman said in a letter to employees, adding that the for-profit LLC will transition to a public benefit corporation.

The company was earlier expected to shift to a for-profit governance structure, potentially helping the Microsoft ( MSFT )-backed company to offer equity to retain top talent and attract new investors who are looking for more financial returns.

"We made the decision for the nonprofit to stay in control after hearing from civic leaders and having discussions with the offices of the Attorneys General of California and Delaware. We look forward to advancing the details of this plan in continued conversation with them, Microsoft ( MSFT ), and our newly appointed nonprofit commissioners," the startup said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly Expands Zepbound Vial Dose Options, Cuts Weight-Loss Drug's Prices for Self-Pay Patients
Eli Lilly Expands Zepbound Vial Dose Options, Cuts Weight-Loss Drug's Prices for Self-Pay Patients
Feb 25, 2025
01:57 PM EST, 02/25/2025 (MT Newswires) -- Eli Lilly ( LLY ) on Tuesday launched higher doses of Zepbound, or tirzepatide, in single-dose vials and reduced the prices of two smaller doses of the weight-loss drug for self-pay patients. The pharmaceutical giant said the new 7.5-milligram and 10 mg vials are available for $499 a month under a new self...
MGE Energy's Q4 Earnings, Revenue Rise
MGE Energy's Q4 Earnings, Revenue Rise
Feb 25, 2025
01:46 PM EST, 02/25/2025 (MT Newswires) -- MGE Energy ( MGEE ) reported Q4 earnings Tuesday of $0.61 per diluted share, up from $0.55 per share a year earlier. A single analyst polled by FactSet expected $0.84 per share. Operating revenue for the quarter ended Dec. 31 was $171.4 million up from $164.7 million a year earlier. Analyst estimates weren't...
Procter & Gamble Insider Sold Shares Worth $3,089,880, According to a Recent SEC Filing
Procter & Gamble Insider Sold Shares Worth $3,089,880, According to a Recent SEC Filing
Feb 25, 2025
01:53 PM EST, 02/25/2025 (MT Newswires) -- Gary A Coombe, CEO, Grooming, on February 25, 2025, sold 18,000 shares in Procter & Gamble ( PG ) for $3,089,880. Following the Form 4 filing with the SEC, Coombe has control over a total of 23,816 common shares of the company, with 22,051 shares held directly and 1,765 controlled indirectly. SEC Filing:...
Datadog Unusual Options Activity
Datadog Unusual Options Activity
Feb 25, 2025
Investors with a lot of money to spend have taken a bullish stance on Datadog ( DDOG ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this big...
Copyright 2023-2026 - www.financetom.com All Rights Reserved